Duke Clinical Research Institute
-
-
Administers Grant
-
"CTN-0060: Adolescent Screening and Brief Intervention (ASBI)"
-
"HiLo": Pragmatic trial of higher vs. lower serum phosphate targets in patients undergoing hemodialysis
-
1/2 IMPACt-LBP CCC
-
1/2 IMPACt-LBP CCC
-
1/3 Multi-Site - Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN)
-
2/2 A comparison of individualized vs. weight based protocols to treat vaso-occlusive episodes in Sickle Cell Disease (COMPARE VOE)
-
2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC
-
2/2: Implementation of the American College of Physician guideline for low back pain using a Multidisciplinary Conservative Care (MC2) model at the initial point of patient contact: A cluster randomized trial (IMPACt-LBP)-DCC
-
2/3 Multi-Site - Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN)
-
2/5 HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study
-
3/3 Multi-Site Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN)
-
4D MT - 4D-310_Follow Up - Taiwan
-
A Biomarker Study of the APEX-AMI and SOLSTICE Trial Populations
-
A CHF Trial Investigating Outcomes of Exercise Training
-
A Collaboration for Improving Outcomes of African Americans with Heart Failure
-
A Descriptive Study for King Hussein Cancer Center
-
A Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Two Doses of T3D-959 in Subjects with Mild to Moderate Alzheimer's Disease
-
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects with Chronic Heart Failure with Reduced
-
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Laboratory Classroom Study with KP415 in Children with Attention-Deficit/Hyperactivity Disorder
-
A PROGRAM OF THREE STUDIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
-
A PROSPECTIVE, MULTI-CENTER, SINGLE-ARM INVESTIGATIONAL STUDY IN HIGH OR EXTREME RISK PATIENTS WITH SYMPTOMATIC, SEVERE NATIVE AORTIC STENOSIS
-
A Phase 1 Study of AAV8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
-
A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn's Disease
-
A Phase 1b MAD Study of TT301/MW189
-
A Phase I Study of the Kappa Opiate Receptor Occupancy and Clinical Mu Opiate Receptor Effects Associated with Repeated Dosing of LY2456302 Trial
-
A Phase III Multi-Center, Randomized, Open-label, Comparative Study to Assess the Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Patients with Intravenous Catheter-Associated Bloodstream Infections (BSI) due to Staphylococci
-
A Phase III, Multicentre, Randomised, Double-blind, Chronic Dosing, Parallel Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of MEDI3506 in Participants with Symptomatic Chronic Obstructive Pulmonary Disease
-
A Quality Improvement Approach to the Management of CLL--Research
-
A Randomised, Controlled, Phase 3 Study of the Safety and Efficacy of Intracerebral Stem Cells (CTX0E03 DP) in Patients with Disability Following an Ischaemic Stroke
-
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, PK, and PD Effects of REGN2477-1033 in Obese Patients with Type 2 Diabetes Mellitus
-
A Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of Escalating Single Doses of ITI-214 in Patients with Systolic Heart Failure
-
A Randomized, Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
-
A cohort study of symptom burden and therapeutic selection in Neuroendocrine Tumors (NETs)
-
A phase 1b double-blind, randomized, placebo-controlled, multicenter, dose titration study to evaluate the safety, tolerability, and pharmacokinetics of 4 weeks treatment with BAY 2413555 in participants with heart failure and implanted cardiac defib
-
A phase 2b/3 Randomized Clinical Trial of Clazakizumab in Patients with End Stage Kidney Disease Undergoing Dialysis
-
AASLD Innovation Fund
-
AB22002 - A dose-ranging study to investigate efficacy and safety of buntanetap in participants with early AD
-
ABCs of North Carolina Plan A
-
AC220-A-U302 trial
-
ACC/Duke Partnership for a National Cardiovascular Research Infrastructure (NCRI)
-
ACE-083_DCRU
-
ACHN-490-007 Trial
-
ACO Model and Comprehensive ESRD Care Initiative
-
ACOSOG Competing Renewal
-
ACOSOG Grant Year 11
-
ACOSOG Supplemental Z1072
-
ACT-EARLY
-
ACTG A5327 Protocol Chair Support (PCS)
-
ACTG, Aids Clinical Trials Group
-
ACTG, Aids Clinical Trials Group Hepatitis TSG Vice-Chair
-
ACTION EQOL STUDY
-
ACTIV -6
-
ACTIV IV COVID-19 Post-hospital Thrombosis Prevention Study
-
ACTIV-1
-
ADAPTABLE Manuscripts
-
ADAPTABLE Supplement
-
AKL-T01 ADHD Adjunctive
-
AMETHYST Trial Collaboration
-
AMG 986_20150183
-
AMG785-2015242
-
AMGEN - FY21 Think Tank AB
-
ARAMIS Registry (Daiichi Sankyo, Inc.)
-
ARLG Administrative Supplement
-
ASCVD EHR Cohort - CardioHealth Alliance Project
-
ASCVD LEARNING LAB
-
ASSESS
-
ATHERO Alliance Learning Lab
-
AUGUSTUS_Extension
-
AZ Pulse Ox Study_LOI
-
Abbott Leadless Pacemakers
-
Accelerating Adoption of Comparative Effectiveness Research in Premature Infants
-
Acquisition of FDG PET Registry Data (NOPR Data Audit) 20-DKE-12
-
Adenosine Contrast CorrELations in Evaluating RevAscularizaTION
-
Admin Supplement: Parmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy
-
Administrative Claims-based Efficiencies for the Advancement of Regulatory Sciences
-
Advanced Haplotype Analyses in Coronary Artery Disease
-
Advancing Medical Device Postmarket Surveillance Infrastructure and Epidemiologic Methodologies through Multi-stakeholder Partnership (U01)
-
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial
-
An Escalating Multiple Dose Study of ABT-555 in Subjects with Relapsing Forms of Multiple Sclerosis
-
An Innovative Model to Predict Readmissions in Adults with Cardiovascular Disease
-
Analysis of associations between anemia correction in CKD and mortality: CHOIR
-
Anatomic and Physiologic Determinants of Vessel-Specific Ischemia by Coronary CT
-
Anti-psychotic Treatment
-
Antibacterial Resistance Leadership Group (ARLG)
-
Anticoagulation Using the Direct Factor Xa Inhibitor Apixaban During Atrial Fibrillation Catheter Ablation: Prospective, Randomised, Open, Blinded Outcome Comparison to Vitamin K Antagonist Therapy
-
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)
-
Anxiety, Depression, and Non-Cardiac Chest Pain
-
Apple Watch IDMC
-
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants
-
Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
-
Assessing the Use and Understanding of Certificates of Confidentiality
-
Assessment of Outcomes and Bleeding Complications Following Implantation of DES and DAPT
-
Assessment of a personalized health care intervention for chronic daily headache
-
Assessment of the Number of Patients Treated for In-stent Restenosis using the Duke Health System
-
Association of MitraClip Availability and Hospital Surgical Mitral valve Repair Volume and Mortality
-
Astellas Prostate Cancer - Part 2 DECIDER
-
Automating Quality and Safety Benchmarking for Children: Meeting the Needs of Health Systems and Patients
-
BAY 2413555 in pts w HF and ICD
-
BCBS/BMP - Subcontract - Technology Assessment - Bone Morphogenetic Protein
-
BEST-VIVA Registry (vCLI)
-
BEST-VIVA Registry (vCLI)
-
BI - CKD PHSR Study
-
BMS-986231_Heart Failure
-
BODYPORT - Protocol Dev - Industry
-
BRIDGE CCC
-
BRIDGE DCC
-
BUILD
-
Bacteremia Modification 14
-
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
-
Barriers to Optimal Cardiovascular Medication Use in Diabetes and Renal Disease
-
Baseline Research Consortium
-
Baseline Study
-
Bayer-20115-CONVERT
-
Bayer-21170-RE-THINc
-
Bayesian II (Subproject under TO3 of 290200710066-I)
-
Benefit Risk Tradeoffs Associated with PRO for PAD
-
Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period
-
Best Pharmaceutical for Children Act (BPCA): Use of Meropenem in Infants
-
Beta-Blocker Evaluation Of Survival Trial (Best)
-
Biomarkers of Caloric Restriction in Humans: the CALERIE Biorepository
-
Biomarkers of Dietary Intake and Exposure Data Coordinating Center
-
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
-
Biosensors Registry for BioFreedom Drug Coated Stent (DCS) - LOI
-
Bladder Cancer in Older Adults - Treatment and Outcomes
-
Blood pressure, endothelial cell dysfunction and outcomes in kidney disease
-
Blood-SCAN Feasibility Evaluation, Phase 3
-
Boehringer Ingelheim Pharmaceuticals Inc - Industry - BI 655130 in Ulcerative Colitis Subjects
-
Broad-based Support for the DEcIDE Research Network
-
Building UDI Into Longitudinal Data for Medical Device Evaluation (BUILD)
-
Burden of Illness
-
CABANA EQOL Trial
-
CABANA-AF Trial
-
CALERIE
-
CALERIE
-
CALERIE Non-competing Extension with Funds
-
CARRA Accelerating Toward an Evidence Based in Pediatric Rheumatology
-
CARRA Planning Grant-Subcontract to UAB
-
CARRA: Accelerating Toward an Evidence Based Culture in Pediatric Rheumatology
-
CARRA_Cooperative Agreement for Clinical Research in Children with Rheumatic Disaeses
-
CASCADE Registry
-
CAT-HF: Arrhythmias Costs
-
CAT-HF: Biomarkers Costs
-
CBER Study of Adverse Effects in use of TNF Inhibitors
-
CCC: The Regional Approaches to Cardiovascular Emergencies- Cardiac ARreSt (RACE-CARS) Cluster-Randomized Trial 1/2
-
CD34+ Biologics
-
CEC Activities for BPR-CS-009 Ceftobiprole medocaril
-
CEC Activities for BPR-CS-009 Ceftobiprole medocaril - WO2
-
CEC Adjudications for Lilly GIP_GLP1
-
CEHI Claire Osgood
-
CEHI Data Management
-
CF-301 Phase III
-
CF-301-102 Study
-
CHAMP-HF
-
CHANGE AF
-
CHARACTERIZING THE ILD CARE CONTINUUM USING REAL-WORLD EVIDENCE
-
CHEER Migraine Study
-
CHS
-
CHS
-
CIAO-ISCHEMIA
-
CISA
-
CISA TO2 Prophylactic Antipyretics
-
CISA-Task Order 1: Option 1
-
CMS Linkage
-
CMS Linkage in Distributed Data Research Networks - Pilot Project
-
CN-105 Study
-
COMPARE UF
-
COMPARE-UF
-
CONNECT-HF
-
COORDINATE Diabetes Study
-
COVID 19_Protocol Development LOI
-
COVID 19_SUA
-
COVID seroconversion in abatacept and control children in LIMIT-JIA
-
COVID-19 Electronic Health Data Initiative
-
CPM Analysis
-
CRISP-AMI Data Analysis
-
CSL112_STEMI
-
CSP 442 - #1416
-
CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study
-
CTOT - CFF - Extension
-
CTOT Long-Term Extension Study
-
CTTI U19
-
CV Precision Medicine Research Alliance - Governance
-
CVH CRG Program
-
Cameo Registry Manuscript only
-
Cancer Tx with a PARP Inhibitor VS Standard
-
Cardiac Spectral Analysis (CRDD1008) TO#3-WA3
-
Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study (Yale Subaward)
-
CardioHealth Alliance Membership
-
CardioHealth Alliance Membership
-
CardioHealth Alliance Membership
-
CardioHealth Alliance Membership
-
Cardiomyopathy associated with Friedreich¿s Ataxia
-
Cardiovascular Cell Therapy Research Network (CCTRN) / CELLVAD-ADRC Protocol
-
Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants
-
Cardiovascular Risk Profile of LAL Deficiency Patients
-
Career Development in Outcomes Assessment in Congenital Heart Surgery
-
Caregivers Survey
-
Centers for Cardiovascular Outcomes Research
-
Characterization of Lp(a) Testing in a Network Consortium
-
Characterization of Patients with Heart Failure and Patients with Vascular Disease and Atrial Fibrillation in Duke University Health System Data
-
Characterization of Patients with Heart Failure and Patients with Vascular Disease and Atrial Fibrillation in PCORnet Data
-
Cilta-Cell
-
Citizen Science COVID Outcomes
-
Claret Sentinel System Statistical Analysis
-
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and your Children (COA APTIC)
-
Clinical Pharmacokinetics and Safety Trials in Down Syndrome
-
Clinical Phenotypes and Outcomes Associated with Tricuspid Regurgitation
-
Clinical Practice Data to Aid Narrow Therapeutic Index Drug Classification
-
Clinical Predictors of Antiretroviral Failure
-
Clinical Trial Services Agreement with bioCSL to Study the Performance of CSL Trivalent Influenza Vaccine
-
Closing the Quality Gap Series: Revisiting the State of the Science - "Medical Home"
-
ClotChip
-
Cognitive Behavioral Therapy and Real-Time Pain-Management Intervention for Sickle cell via Mobile Applications (CaRISMA)
-
Collaboration between Duke University and the NIAID
-
Collaborative Research on the Clinical Effectiveness and Long-term Outcomes of Stents in Coronary Interventions
-
Collaborative Research on the Clinical Effectiveness and Long-term Outcomes of Stents in Coronary Interventions
-
Collaboratory Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) (U24)
-
Community-based Assessment of Skin Care, Allergies and Eczema (CASCADE)
-
Comparative Effectiveness Reveiws for MMA Section 1013
-
Comparative Effectiveness Reviews for MMA Section 1013
-
Comparative Effectiveness of CARRA Treatment Strategies for Polyarticular Juvenile Idiopathic Arthritis
-
Comparative Effectiveness of Medications Used in Congenital Heart Surgery
-
Comparative Effectiveness of Pharmacogenomics for Treatment of Depression (CEPIO-D)
-
Comparative Effectiveness of Therapies for Heart Failure
-
Comparative effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension
-
Comparing Options for Management: Patient-centered Results for Uterine Fibroids
-
Comparison of Methotrexate and Biologics in JIA (COMPARE-JIA)
-
Comprehensive EPC Comparative Effectiveness Reviews for Effective Health Care
-
Computer-based guidelines to prevent sudden cardiac death
-
Congestive Heart Failure Device
-
Considering Patient Preferences in Chronic Cough
-
Consultation for the Stanford Microbiome Therapies Initiative
-
Cooperative Multi-Center Reproductive Medicine Network
-
Coordinating Center for CERTs
-
Coordinating Center for DILIN
-
Coordinating Center for the Drug Induced Liver Injury Network (DILIN)
-
Coordinating Center for the Drug Induced Liver Injury Network (DILIN) - Competitive Renewal
-
Coordinating Center for the Drug Induced Liver Injury Network (DILIN)- Supplement
-
Core variable Assessment Towards a NatIonal evaluation Program (CATNIP) - Subcontract with Weill Cornell
-
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study
-
Creating a Pulmonary Fibrosis Foundation Patient Registry and Care Center Network
-
Creating the Learning Healthcare Platform of the Future: High Risk ASCVD Registry for Longitudinal follow up
-
Creating, Implementing, and Sharing Best Practices for Clinical Trials Networks
-
Creation and demonstration of a palliative care research cooperative group
-
DAP Phase I PK/PD Analysis Budget
-
DCC: Regional Approaches to Cardiovascular Emergencies- Cardiac ARreSt (RACE-CARS) Cluster-Randomized Trial 2/2
-
DCRI CARRA Registry
-
DCRI CERT for Cardiovascular Therapies
-
DCRI Research Center for CERTs
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank
-
DCRI Think Tank-BI
-
DCRI Think Tank-Eli Lilly
-
DCRI Think Tank-Sanofi
-
DCRI-Stanford CEC Summit
-
DCRI-Stanford CEC Summit
-
DCRI-Stanford Symposium
-
DCRI-Stanford Symposium
-
DE40 Xeries XSGR-PBH-201
-
DECIDE 2
-
DEFINE-PCI
-
DELIVER HF EHR SCREENING INITIATIVE
-
DEcIDE AVR
-
DEcIDE DES TO4 W3
-
DEcIDE Health Outcomes of Carotid Artery Disease
-
DEcIDE Stents TO4 WA2
-
DG29 SERES
-
DI7: Creating a Sentinel linked EHR-Claims Development Network (WO2020)
-
DN44 Acceleron extension
-
DRI13940 Study
-
Data Characterization of DUHS data for Amgen project
-
Data Coordinating Center For Scd In Heart Failure Trial
-
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - VDORA 1
-
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - VDORA 1
-
Data and Statistics Center for the Clinical Trials Network
-
Decide 2 Administrative Task Order for Travel to AHRQ
-
Decision Making by Patients Seeking Care for Fertility Problems
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
-
Development of national registry for patients receiving primary care in the home
-
Diabetic Retinopathy
-
Dialysis Facility Management
-
Digital Diagnostic Treatment Solutions for ADHD- LOI
-
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease
-
Digoxin Toxicity Study
-
Direct Administration of AdVEGF-All6A+ LOI
-
Disease Recapture After Drug Discontinuation and Flare in JIA
-
Duke Administrative Work Assignment - ADMD0508 - TO#3-WA5
-
Duke Cardiovascular CERTs
-
Duke Summer Training in Academic Research (Duke's STAR)
-
Duke Summer Training in Academic Research (Duke's STAR) BIOGEN
-
Duke Summer Training in Academic Research (Duke's STAR) BIOGEN
-
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program
-
Duke-UNC Sickle Cell Disease Clinical Research Network
-
Dupilumab Food Allergy Program
-
Dupilumab Food Allergy Program
-
Dyanavel Efficacy Study
-
Dyanavel Safety Study
-
Dynamic Outcomes Assessment in Multi-Center Trials
-
ECHO Administrative Supplement - Neonatal Opioid Exposures
-
ECHO Coordinating Center Administration Core
-
ECHO IDeA States Pediatric Clinical Trials Network - 2 (U24)
-
EEG Coordinating Center
-
EFC 13794
-
EGFR Testing Patterns and Outcomes in Non-Small Cell Lung Cancer in the VA Health System
-
EMPA MI Jardiance®, empagliflozin
-
EMPA-KIDNEY Trial
-
ENDOMAX CEC and DSMB
-
ENHANCING THE CALERIE NETWORK TO ADVANCE AGING BIOLOGY
-
EPC Project: ECG Update
-
EPC Project: Medical Test Guide
-
EPC Project: Medical Test Guide (2nd phase)
-
EPC Project: Medical Test Guides - training modules
-
EPC Project: Mental Health
-
EPC Technical Support of the Technology Assessment Program 75X1700 8-K720001 25505
-
EPC V Admin Task TO1- Admin Task-Methods and Dissemination: Collaboration to improve validity,
consistency, and utility of systematic reviews
-
EPC _TO #1_WA #3_Anemia Management in Renal Disease Populations - (Part 1)
-
EPC: Postpartum Depression
-
EPC_TO#2_WA#3_Comparative Effectivness of ACEIs and ARBs foor Treating Essential Hypertension
-
EPC_TO#3_WA#7_Anemia Management in Renal Disease Populations - Part 2
-
ESCAPE - Evaluation Study of Congestive Heart Failure and Pulmonary Artery Cathetorization Effectiveness
-
ESCAPE Mechanistic Substudy Grant Application
-
Early Diagnosis of Neonatal Candidiasis
-
Echocardiogram to Diagnose Pulmonary Hypertension in Premature Infants
-
Economic Analysis for the ATlantic C-PORT Trial
-
Economics and Quality of Life in OAT
-
Economics and Quality of Life in SCD HEFT
-
Edios AG10-304 CM Extension Study
-
Educational Videos to Reduce Racial Disparities in ICD therapy Via Innovative Designs (VIVID)
-
Effectiveness of disease-modifying anti-rheumatic drugs (DMARDs) in children with juvenile idiopathic arthritis (JIA)
-
Efficacy of Antiviral Suppression Therapy after Neonatal HSV Infection of the CNS
-
Efficiencies for Outcome Ascertainment throughout the Total Product Life Cycle
-
Electronic Knowledge Management and Clinical Decision Support-TO5
-
Enabling Real-time, Personalized Engagement in Research: an App-based Approach
-
Engaging patients, community, and health system stakeholders to establish PCOR priorities
-
Engaging, Inspiring, and Preparing the Next Generation of Biostatisticians
-
Enhancing CARRA Research: Integration and Dissemination of Clinical Data
-
Enhancing the U.S. Public Health System's Willingness and Capacity to Engage in Clinical Research
-
Eosinophilic Esophagitis (EoE)
-
Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO
-
Epilepticus_EEG Coordinating Ctr.
-
Establishment and Maintenance of the Innovation Center
-
Ethical Approaches to Genotype-Driven Research Recruitment
-
Ethical Approaches to Research Use of Clinical Records and Data
-
Evaluating and Improving Cardiac Arrest Resuscitation Efforts in Hemodialysis Clinics
-
Evaluating fitness-for-use of Electronic Health Records in Clinical Research
-
Expanding HL7 FHIR to support post-marketing research and surveillance within multi-source, chronic disease registries
-
Exscel Biomarker Analysis and Secondary Manuscript Production
-
Extraction Vs Capping Pacing and Defibrillator Leads
-
FAST- MAS Administrative Task Year 2
-
FAST- MAS Administrative Task Year 3
-
FDA Crusade Database Query
-
FY22-Think Tank AB
-
FY23 Think Tank AB
-
Fast-Fail Trials in Mood and Anxiety Spectrum Disorders (FAST-MAS)
-
Financial Assistance, Navigation, and Communication Education (FinANCE): Development and pilot testing of a web-based financial toxicity intervention
-
Financial and Social Behavioral Economic Incentives to Increase Physical Activity in Adolescents and Young Adults for Cardiovascular Health
-
Fitness-for-Use of Electronic Health Records as Source Data for Clinical Research
-
Fitness-for-Use of Electronic Health Records as Source Data for Clinical Research Option Period 3
-
Fitness-for-Use of Electronic Health Records as Source Data for Clinical Research- Option 1
-
Fitness-for-Use of Electronic Health Records as Source Data for Clinical Research- Option 2
-
Flume Comfort Study
-
Framingham Study - Amendment 3
-
From Clinic to Community: Achieving Health Equity in the Southern United States
-
GAD and MDD Study
-
GARFIELD-Atrial Fibrillation Registry Research
-
GBGJ Dulaglutide_CEC
-
GDF-15 FIGHT/RD003507
-
GSK-CKD program_CEC
-
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
-
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
-
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)
-
Gene Therapy 4D-310 in Adult Males with Fabry Disease
-
General DEcIDE Network Support: Methods and Dissemination
-
General EPC Support: Methods and Dissemination
-
Get With The Guidelines AHA Measure Reliability Testing SOW #18
-
Gilead GS-US-334-0107 LOI
-
Global Pediatric Clinical Trials Network
-
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment (EQOL)
-
H9X-MC-GBGO
-
HCM Video Development project
-
HCQ Pharmacokinetics in Pediatric Lupus
-
HCV/HIV Co-infection Registry
-
HEAL Clinical Coordinating Resource Center for the Pain Management Effectiveness Research Network
-
HEOR_RandD_RFP_RWE for Regulatory Use
-
HERO Program, HERO Registry, HERO-HCQ Trial
-
HF Action Supplement
-
HF Mgmt LOI
-
HFN / HIV Supplement
-
HFN LIFE Industry Supplemental Funding
-
HO-15-16139: Clinical, Epidemiological, and Health Economic Characteristics of Acute Decompensated Heart Failure Patients with Varying Degrees of Respiratory Involvement
-
HUMAN USE CONDITION STUDY ASSOCIATION FOR ADVANCEMENT OF MEDICAL INSTRUMENTATION FLUOROSCOPIC EVALUATION OF 3D CURVATURE OF IMPLANTED LEADS IN HUMANS
-
Health Care Systems Research Collaboratory - Coordinating Center
-
Heart Failure : Epidemiology & Outcomes in the Elderly
-
Heart Failure Clinical Research Network - DCC
-
Heart Failure Network: Year 12 Non-Compete Renewal
-
Heart Rescue Flagship Premier Partner Program "RACE CARs"
-
Heart/Lung Transplant Study
-
HeartRescue
-
HeartRescue
-
HeartRescue Brazil (RAPIDO)
-
Hero Ancillary Study: The Nurse HERO Study
-
Hypericum Perforatum In Depressive Disorder, Coordinating
-
Hyperinsulimia and Insulin Resistance in Nonalcoholic Fatty Liver Disease
-
ICD Therapy in Patients with Congestive Heart Failure
-
ID-076A301; SOS-AMI; Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of subcutaneous self-administration of selatogrel for preventi
-
IMPACCT
-
IMPROVE STROKE
-
IMPROVE Stroke Care Systems of Care Research Program
-
INSPIRE
-
IPA - Mary Elizabeth Wing
-
IPA - Mary Elizabeth Wing
-
IPA - Patricia Cowper
-
IPA - Patricia Cowper
-
IPA - Remy Coeytaux
-
IPA-Mary Liz Wing
-
IPA-Robyn Schmidt
-
IPA-VA Palo Alto OPTIMA
-
IPF Wrap
-
ISCHEMIA-CKD SDCC
-
ISCHEMIA-Extend_Resubmission
-
ITI Parkinson's Disease Study
-
ITI-214-104
-
IW-1973 Caplet
-
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
Idiopathic Pulmonary Fibrosis Clinical Research Network NCE
-
Immunoglobulin Therapies Based on Treatment Experience
-
Immunological biomarker studies in myasthenia gravis
-
Impact of early discharge following bypass surgery
-
Implementation of Demonstration Project for Health Systems: Atrial Fibrillation(INFORM-AF)
-
Implementing Research Findings for Practice Improvement
-
Improvement of interoperability of healthcare data
-
Improving Data Completeness and Expanding Available Data Elements in the TVT Registry through the use of Electronic Health Record Based Data: Linking the TVT Registry and PCORnet
-
Improving Methods for Comparative Effectiveness Research in Cardiovascular Care
-
Improving Neonatal health Through Rapid malaria testing in Early Pregnancy with high-sensitivity Diagnostics (INTREPiD)
-
Improving Outcomes in Limited Juvenile Idiopathic Arthritis
-
Improving Veteran Access To Integrated Management of Chronic Back Pain (AIM Back)
-
Improving stroke risk prediction with cohort data and machine learning methods
-
Increasing Patient and System Value with Community Based Palliative Care
-
Increasing Patient and System Value with Community Based Palliative Care
-
Increasing the Quality and Efficiency of Clinical Trials (U18)
-
Indiana University Intramural Grant - Echocardiographic Image Analysis
-
Indiana University Intramural Grant - Genetic Biorepsitory
-
Inflammation & Prognosis in Decompensated Heart Failure
-
Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials (IMPACCT)
-
Inhalant Use/Dependence: Incidence and Co-Morbidity
-
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects with Known Lambert-Eaton Myasthenic Syndrome (LEMS) [JPC 3,4-DAPPER]
-
Integrating Palliative Care in Oncology Practice
-
Investigating polypharmacy-related adverse events in critically ill children using electronic health records and simulated drug levels
-
JTT-251_HF Trial
-
Jackson Heart Study
-
Janssen AF Quality Improvement Research Study
-
Janssen HERO Vaccine Trial Start Up Budget
-
Janssen TIDM Diabetes Study
-
KOR Phase 2A Study - Mod 3 (Advanced Understanding)
-
LEADER Trial: Association between weight change and cardiometabolic risk factors in a real-world population of U.S. Adults
-
LUX PERFORM
-
Landscape Analysis -BI US CKD Study
-
Leadership and Operations Center (LOC) AIDS Clinical Trials Group (ACTG) Protocol Chair Support for A5380
-
Leadership and Operations Center (LOC), Aids Clinical Trial Group (ACTG) HEP Committee Chair
-
Leadership and Operations Center (LOC), Aids Clinical Trial Group (ACTG) HEP Committee Chair - Transformative Science Group
-
Legacy Effects of CALERIE, a 2-year Calorie Restriction Intervention, on Hallmarks of Healthspan and Aging
-
Leslie Walker IPA (VA-funded project IIR #05-273-2 )
-
Leveraging Real World Evidence to Understand Contemporary Medical and Surgical Care
-
Leveraging registry resources for efficient and cost effective clinical trials
-
Li Lin support from MCW
-
Lilly GPGB Diabetes Study
-
Limbix Spark: a CBT-based mobile intervention for adolescent depression (NIH FUNDING)
-
Linking Safety Practices to Adverse Events and Outcomes in Hospitalized Infants
-
Lung Microbiome Study in IPF
-
Lung Microbiome Study in IPF
-
Lung Repair and Regeneration Consortium Administrative Coordinating Center
-
Lung Transplant Clinical Trial Network (LT-CTN)
-
Lung Transplant Consortium - Data Coordinating Center
-
Lupus Learning Lab
-
MACE COMMITTEE COLLABORATION LOI
-
MDEpiNet J&J Dues
-
MDEpinNet: RAPID Phase II
-
MEDpiNET: Industry Funding
-
MESA
-
MESA
-
MG 302 Extension (RAISE XT)
-
MITRAL Trial
-
MK1242-035-CEC
-
MOM-M281-004
-
MOM-M281-005
-
MOST Administrative Statistical Support
-
MYK-461-004: Phase 2a and 2b Program
-
Maintenance of the Innovation Center (IC) (Year 4) WO 2000.3
-
Major Depression with Suicidal Ideation
-
Malaria chemoprevention in children with sickle cell anemia in Western Kenya
-
Managed Care Features Affecting Quality for CAD Patients
-
Managing the Risks of Therapeutic Products
-
Managing the Risks of Therapeutic Products, January 12-14, 2003.
-
Mapping Quality in the Stroke System of Care: Do hospitals that share in the care of Acute Stroke patients also share
-
Marital Trajectories and Cardiovascular Disease in the United States
-
Master Plan for Integration of Innovation Technologies and IC Collaboration Activities
-
Master Plan for Integration of Innovation Technologies and IC Collaboration Activities (Year 4) WO2018
-
Mavacamten Manuscripts
-
Mechanisms of Hormone Therapy in Post-Menopausal Women
-
Medtronic Stroke Initiative
-
Meningitis B Vaccine European study
-
Mentoring in Clinical Pharmacology and Early Phase Trials
-
Mentorship of early-career pediatricians in quantitative methods and therapeutics
-
Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)
-
Methodology for Linking Clinical and Administrative Databases
-
Methods and Dissemination
-
Mission Lifeline Texas State System Report
-
Mission Lifeline Texas State System Report
-
MitraClip
-
MitraClip Procedure versus Surgery
-
Mod 11 for Option 3 - Staphylococcal Bacteremia Study
-
Modification No 13 Staphylococcal Bacteremia Study
-
Modification No. 5 - Staphylococcal Bacteremia Study
-
Modification No. 8 - Staphylococcal Bacteremia Study
-
Modified KOR Phase 2A Study
-
Molecular Atlas of Lung Development - Data Coordinating Center
-
Moving Towards More Individualized Therapies in HIV/HCV Co-infected Patients
-
MyoKardia HCM App
-
Myocardial Ischemia and Transfusion (MINT) Steering Committee
-
NCDR-ACTION
-
NESTcc Data Quality Committee
-
NIA AD/ADRD Health Care Systems Research Collaboratory
-
NIDCD R21/R33 Phased Infrastructure Grant for Patient-Oriented Research
-
NIDCD R21/R33 Phased Infrastructure Grant for Patient-Oriented Research
-
NIH Health Care Systems Research Collaboratory - Coordinating Center
-
NIH Health Care Systems Research Collaboratory-Coordinating Center (U24 Clinical Trial Not Allowed)
-
NIH Single Instiutional Review Board (sIRB)
-
NIH State of the Science Conference on Preventing Alzheimer's Disease and Cognitive Decline
-
NIH Summer Research Experience Programs (R25)
-
NLM Lab Query
-
NOVA-LATAM Lipid Management - Industry
-
NRSA Training Grant for Clinical Pharmacology - Dallefeld and Chaparro
-
Nasal Polyps
-
National Drug Abuse Treatment Clinical Trials Network
-
National Longitudinal Outcomes Following Surgical Therapy for Lung Cancer
-
National Surveillance of Stroke Outcomes and Quality of Care using the Get With the Guidelines(GWTG) Stroke Registry
-
National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer and its Effect on Health Disparities, Chemotherapy Utilization, and Associated Costs
-
National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer and its Effect on Health Disparities, Chemotherapy Utilization, and Associated Costs
-
Nationwide Utilization of Cardiac Imaging In Cancer Patients
-
NeSTcc Test Case 6 Johnson and Johnson Certus device
-
New Advances in HFrEF: Learning Lab
-
Nitroprusside in Children (NITPIC)
-
North Carolina Collaborative PPRU Network
-
North Carolina Congenital Heart Defects Surveillance Network
-
Novel T2DM Therapies
-
OCEANIC
-
OCEANIC-AF
-
ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment with Alirocumab
-
ODYSSEY RCC
-
ODYSSEY RCC
-
ORBIT AF
-
Odyssey RCC
-
Omecamtiv Mecarbil in Heart Failure
-
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients with Invasive Fungal Infections that are Refractory to or Intolerant of Standard Antifungal Treatment (FURII)
-
Operationalizing Patient-Reported Outcomes Measurement with Electronic Health Records in Patients with Heart Failure
-
Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis
-
Optimizing Health Outcomes in Patients with Symptomatic Aortic Valve Disease
-
Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery
-
Optimizing duration of antibiotics after valve surgery for infective endocarditis
-
Optimizing the Electronic Health Record for Cardiac Care
-
Optimizing treatment for E. faecalis infective endocarditis: ampicillin plus ceftriaxone versus ampicillin plus gentamicin
-
Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
-
Oral Doses of MYK-491 in Patients with Stable Heart Failure
-
Outcomes Database to prospectivelY aSSEss changing therapY landscape in Renal Cell Carcinoma (ODYSSEY RCC)
-
OxyContin Pediatric PMR Study
-
Oxycontin Peds Study (EPM 7254)
-
P1CTU_Task Order 16_Protocol Development
-
P1CTU_Task Order 16_Protocol Implementation
-
PACTTE-Partnership for Anemia: Clinical and Translational Trials in the Elderly
-
PAH trial of GB002
-
PAH_POC
-
PARADISE
-
PARTNERS
-
PARTNERS Extension
-
PCI QA Review
-
PCORI Short Term Communications Procurement Plan
-
PCORI_Triage and FR Prioritization - Amendment #3
-
PCORI_Triage and FR Prioritization - Amendment #4
-
PCORNet Communications - Engagement Materials
-
PCORnet CC - SCOPE 1: Program Management, Collaboration and Coordination
-
PCORnet CC - SCOPE 2: Common Data Model Maintenance, Expansion and Linkage
-
PCORnet CC - SCOPE 4: Strategic Communications to Support the PCORnet Research Community
-
PCORnet Phase II Rapid Research TO#13 Mod 2
-
PCORnet Phase II TO#15
-
PCORnet Phase II TO#17- DCRI Leadership
-
PCORnet Phase II TO#18- HPHC Leadership
-
PCORnet Phase II TO#19- DCRI DRN
-
PCORnet Phase II TO#20- HPHC DRN
-
PCORnet TO#16- Privacy-Preserving Record Linkages (PPRL)
-
PCORnet TO#7 Planning Project with Genetic Alliance
-
PDE-1 Inhibitor Study- LOI
-
PERFORM- TSIX
-
PHENO (BI Heart Failure Implementation Project )
-
PMR 292932: A Nationally Representative Drug Utilization Study of OxyContin in Children Aged 17 Years and Younger
-
POC 2-D Diffusion Assay for self-monitoring of BNP
-
POPS Lab
-
POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION INITIATIVE (Phase 1)
-
PRA-Ionis ATTR-CM
-
PRECISE
-
PREMIS: Preventive Misconception in HIV Prevention Trials
-
PREVENTABLE Trial Partnership and Meeting Support
-
PROMISE Substudy to Assess For Effective dose of Radiation (PROMISE-SAFER)
-
PROMISE Trial: Clinical Coordinating Center
-
PROMISE Trial: EQOL Coordinating Center
-
PROMISE Trial: SDCC
-
PROVIDE-HF: Patient Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (Valsartan/Sacubitril) in Heart Failure.
-
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
-
PTN LAP01 Registry
-
PTN 2.0 TO #10: Positron-C
-
PTN 2.0 TO #11: CUDDLE 2.0
-
PTN 2.0 TO #TBD: SIL02 Sildenafil
-
PTN 2.0 TO 1 Core Function Activities_Option 2
-
PTN 2.0 TO 1 Core Function Activities_Option 3
-
PTN 2.0 TO 1 Core Function Activities_Option 3.1
-
PTN 2.0 TO 5 Modification
-
PTN 2.0 TO 6 Down Syndrome Extension
-
PTN 2.0 TO 6 Down Syndrome Extension
-
PTN 2.0 TO#4 BPCA Data Closeout and Dissemination - Option 4
-
PTN 2.0 TO1 Core Function Activities - Option 4
-
PTN 2.0 Task Order 7 HIV Lactation
-
PTN 2.0- TO#4/Option 3 Data Closeout and Dissemination
-
PTN 2.0- TO 3 - Option 2 - BPCA Concept Development and Clinical Trial Readiness Support
-
PTN 2.0- TO 3 - Option 3 - BPCA Concept Development and Clinical Trial Readiness Support
-
PTN 2.0: Task order #2 COVID-19 POP02
-
PTN POPS III
-
PTN TO #21- Pharmacokinetics of Multiple Dose Methadone in Children
-
PTN TO #25 SCAMP
-
PTN TO #30 POPS Lab Mod. 2
-
PTN TO #34: Program Management Support
-
PTN TO #34: Program Management Support - Option 2
-
PTN TO #34: Program Management Support - Option 2 Mod 1 (Mod 4)
-
PTN TO #39: PPE
-
PTN TO #41: Sildenafil II
-
PTN TO 22-Bronchopulmonary Dysplasia (BPD) and the Use of Diuretics in the NICU
-
PTN TO 23-The Effect of Obesity on the Pharmacokinetics of Pantoprazole in Children
-
PTN TO# 35 Furosemide II
-
PTN TO# Anesthesia
-
PTN TO#14 (Mod #3) - Efficacy of sildenafil in premature infants with Pulmonary Hypertension
-
PTN TO#36 - PTN Repository
-
PTN TO#37 Efficacy, Pharmacokinetics, and Safety of Topical Timolol in Infants
-
PTN TO#37 Obesity CNS PK Trial
-
PTN TO#38 Efficacy, Pharmacokinetics, and Safety of Topical Timolol in Infants
-
PTN TO#40 (Protocol Development IV)
-
PTN TO#42 HAP
-
PTN TO#42 HAP - Modification #1
-
PTN TO#44 Baby Mercy Tape II (TAP03)
-
PTN TO#47 (Protocol Development V)
-
PTN TO48 - Pharmacokinetics of Anesthetics and Analgesics in Children and Adolescents Extension
-
PTN TO: BPCA INNOVATIVE TRIAL DESIGNS FOR DOSING, SAFETY, and EFFICACY in PEDIATRIC THERAPEUTICS
-
PTN Task Order #10: Ampicillin
-
PTN Task Order #11: Obesity Informatics Database
-
PTN Task Order #12 Protocol Development (RFTOPs)
-
PTN Task Order #13: Pharmacokinetics of Antistaphylococcal Antibiotics in Infants
-
PTN Task Order #14: Sildenafil study
-
PTN Task Order #15: Fluconazole Safety Trials
-
PTN Task Order #16: Pediatrix Safety Study
-
PTN Task Order #17: Bioanalytical Analysis: POPS1, Fluconazole, and Meropenem
-
PTN Task Order #19: Lorazepam
-
PTN Task Order #20: POPS II
-
PTN Task Order #24: Protocol Development II
-
PTN Task Order #28 Baby Tape
-
PTN Task Order #3 - Safety and Pharmacokinetics of Multiple Dose Metronidazole in Premature Infants
-
PTN Task Order #4: Hydroxyurea PK
-
PTN Task Order #5: Acyclovir
-
PTN Task Order #6: Opportunistic Studies
-
PTN Task Order #7: Lisinopril
-
PTN Task Order #8: TAPE
-
PTN Task Order #9: Midazolam
-
PTN Task Order 25 SCAMP Modification
-
PTN Task Order 29: Clindamycin Bactrim
-
PTN Task Order 34 - Program Management Support
-
PTN Task Order 36- PTN Repository: Modification 1
-
PTN Task Order 8 COVID-19 Studies
-
PTN Task Order--Protocol Development III
-
PTN Task Order: CAFFEINE
-
PTN Task Order: Safety of Furosemide in Premature Infants
-
PTN2- TO# 3 Concept Development and Clinical Trial Readiness Support Option Period 1
-
PTN2- TO# BPCA Concept Development and Clinical Trial Readiness Support
-
PTN2- TO# BPCA Pharmacology Studies
-
PTN2- TO# Data Closeout and Dissemination
-
PTN2- TO#4 Data Closeout and Dissemination Option Period I
-
PTN_TO#50 POPS LAB
-
Palliative Care for High-Risk TAVR Patients: The Impact of Multimorbidity
-
Palliative Care in Heart Failure (PAL-HF)
-
Panachen 17582
-
Pantheon 15128
-
Pass-Through cost- CLIN04
-
Pathways to cardiovascular disease prevention and impact of specialty referral in under-represented racial/ethnic minorities with HIV
-
Patient Preference Information: Bridging Regulatory Decisions and Clinical Practice
-
Patient Preference Study
-
Patient Preferences in the Treatment of Diffuse Large B-cell Lymphoma
-
Patient Valued Comparative Effectiveness of Corticosteroids Versus Anti-TF Alpha Therapy
-
Patient preferences targeting PCSK9 protein
-
Patient-Centered Treatment Labeling in Depression
-
Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research
-
Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research
-
Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF
-
Pediatric Crohn's Disease Patient and Provider Risk-Benefit Preferences for Monotherapy versus Combination Therapy
-
Pediatric Trials Network
-
Pediatric Trials Network_ Task Order 1_ Core Function Activities
-
Pediatric Trials Network_ Task Order 1_ Core Function Activities Option Period 1
-
Percutaneous Heart Valve Replacement - HEVA0608
-
Perinatal Quality Collaborative of North Carolina Statistical Support
-
Perinatal Quality Collaborative of North Carolina Statistical Support
-
Ph3 ATTR Cardiomyopathy Study
-
Pharmacokinetics and Pharmacodynamics of Antibiotics in Premature Infants
-
Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass
-
Phase 1 - The Effectiveness of Disease-modifying Anti-rheumatic Drugs in Children with Juvenile Idiopathic Arthritis
-
Phase 1 single-ascending dose study of the safety and pharmacokinetics of 24 hour intravenous 5-HTP (EVX-301)
-
Phase 2 - The Effectiveness of Disease-Modifying Anti-Rheumatic Drugs in Children with Juvenile Idiopathic Arthritis
-
Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development
-
Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development, Year 3
-
Phase I MAD Study of JNJ-55920839
-
Physiologically Based Pharmacokinetics in Critically Ill Children
-
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity
-
Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children
-
Pilot Project applying the National Clinical Research Associates model within the Duke Translational Medicine Institute
-
Platform for Engaging Everyone Responsibility (PEER) Validation
-
Pneumonia LOI
-
Postdoctoral Training in Cardiovascular Clinical Research
-
Power of Bayesian Methods, RCTs, and Decision Models to Inform CRT Uncertainties
-
PrefER WO6
-
Preference Studies in Alzheimer's Disease: General Population Surveys
-
Preference Tx for Sequencing in NSCLC
-
Premier IPF_2
-
Preschool Vision Screening in Primary Care Settings
-
Preserving Kidney Function in Children with Chronic Kidney Disease
-
Preventing Cardiovascular Disease through Improved Risk Prediction and Communication
-
Preventing Sudden Cardiac Death: Harnessing the Power of Decision Analysis, Bayesian Techniques, and Clinical Trials
-
Prevention of Cardiovascular Complications of Pediatric SLE
-
Prevention of Influenza in Infants by Immunization of Their Contacts in the Household (PIIITCH study)
-
Prevention of Invasive Candidiasis: PK, Safety, and Neurodevelopmental Outcomes
-
Prevention of Invasive Candidiasis: PK, Safety, and Neurodevelopmental Outcomes
-
Priovant BREPO
-
Procyrion FIM Device Study
-
Prognostic Discordance in Oncology: what's behind the misunderstanding?
-
Prognostic value of Heart Rate Variability measured by Cardiovascular Implantable Electronic Devices
-
Prospect of Direct Benefit in Pediatric Reseach in Type 1 Diabetes (T1D)
-
Prospective Comparison of Colonic Imaging Tests
-
Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-Modifying Treatments for Myasthenia Gravis (MG)
-
Prostate Cancer in the VA Health System
-
Protocol #s 19765, 19766, and 20603: ACS and Afib Trials
-
Protocol CNTO1275CRD3007
-
QT prolonging medications and sudden cardiac death among individuals on hemodialysis
-
Quality of Care and Resource Utilization in Apparent Treatment Resistant Hypertension
-
Quatifying Patient Preferences for Heart Failure Interventions
-
R21 ICT Tools for Rare Diseases
-
RADx-UP CDCC
-
RAISE
-
RARE DISEASE NETWORK FOR MYASTHENIA GRAVIS
-
RARE DISEASE NETWORK FOR MYASTHENIA GRAVIS
-
RECOVER Infrastructure
-
REHAB HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
-
RESULT Trial-REflux SUrgery in Lung Transplantation
-
REVEAL (Reduction of Infarct Expansion & Ventricular remodeling with Epo Admin after Large MI)
-
ROBUST METHODS FOR THE EFFICIENT ANALYSIS AND INTEGRATION OF DNA SEQUENCE DATA
-
RSV Infant and Older Adults Program Learning Lab
-
RTI-TO2-Newborn Screening Pilot Study for Adrenoleukodystrophy (ALD)
-
RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study
-
Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
-
Real World Assessment of Vascular Device Safety and Effectiveness
-
Reducing Risk of Anthracycline-related Heart Failure after Childhood Cancer
-
Reflexion Virtual Rehab Study
-
Regeneron 20118
-
Regional Systems Accelerator: Implementation of the AHA Mission (TMC)
-
Registry on cost per disability-adjusted life year (DALY) studies
-
Relationship between cerebrospinal fluid penetration of antimicrobials in infants and juvenile animals
-
Remotely Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM
HIIT-Covid19)
-
Representation of Unstructured Data Across Common Data Models (DI2)
-
Rescuing Kidneys at Risk of Discard
-
Resources for Mentorship of Clinician Scientists in Hearing and Balance Disorders
-
Retrospective QTc Analysis for PER977-01-001
-
Rheumatoid Arthritis ABBV-3373
-
Risk Prediction for Secondary Events in Adults with Arteriosclerotic Cardiovascular Disease (ASCVD)
-
Risk prediction for S Arteriosclerotic Cardiovascular Disease (ASCVD) in persons on statins
-
Risk stratification using genetic and microbial determinants in childhood onset RA
-
Roche Diabetes Care_LOI
-
Role of CD4 T cell subsets as drivers of MG disease
-
Role of pharmacokinetics and genomics in tocolytic therapy with indomethacin (subcontract)
-
SAFE STEMI in Seniors LOI for Volcano
-
SAFE-PCI for Women: FDA
-
SCUSF 0806 Phase II placebo--controlled trial of lisinopril and Coreg
-
SCUSF 0806 Phase II placebo--controlled trial of lisinopril and Coreg
-
SEER-CV Registry (EFFECTIVENESS OF PCSK9I IN THE PREVENTION OF CARDIOVASCULAR DISEASE: A GLOBAL REGISTRY REAL WORLD DATA IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE)
-
SOFTAD-Substance use outcomes following treatment adolescent depression
-
SOLI - Solithromycin Pediatric Development Program (Phase 2/3 start up)- MOD 2
-
SOLI - Solithromycin Pediatric Development Program (Phase 2/3)- Labor & Sub Cost
-
SOLI - Solithromycin Pediatric Development Program (Phase IB)- MOD 2
-
SPIRRIT - DCC
-
SPIRRIT-HFPEF - CCC
-
STICH Statistics and Data Coordinating Center
-
STICH Trial - Coordinating Center
-
STICH Trial-Economics & Quality of Life Core Laboratory
-
STICHES
-
Safer Antithrombotic Therapy for Elderly ACS Patients
-
Safety and Effectiveness of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer
-
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia
-
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
-
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
-
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
-
Sample collection to predict response to abatacept in Limit-JIA
-
Sanofi SOTA Outcomes EFC15156
-
Sentinel Innovation Center WO#2
-
Sentinel Innovation Center WO#2-Extension
-
Sentinel Innovation Center WO#5 RWE: Advancing scalable natural language processing approaches for unstructured electronic health record data
-
Sentinel Innovation Center-WO2.0000.1
-
Sentinel Innovation Center-WO2.0004
-
Sentinel WO WO2000.2 Mod #6 Maintenance of the Innovation Center (IC)
-
Sentinel WO WO2013 Mod #7 Identification and mitigation of structured EHR source data mapping issues (DI3)
-
Sentinel WO2012 Mod #6 Master Plan for Integration of Innovation Technologies and IC Collaboration Activities (Year 3)
-
Sentinel WO2016 Mod #8: Approaches to handling partially observed confounder data from (EHR) in NRS of MC
-
Sherry Lloyd CardioHealth Alliance Membership
-
Solicitation APP 111513, Hospital Engagement Contractor
-
Southern Consortium Node of the Clinical Trials Network
-
Spoonfulone
-
Stage III NSCLC in the VA Health System
-
Stakeholder Support and Meetings for the DEcIDE Cardiovascular Consortium
-
Standardized Collection and Submission of Cardiovascular Endpoint Data
-
Standardizing and Optimizing Childhood Lupus Nephritis Treatment through CARRA
-
Stated Therapy Preferences of Child Caregivers and Adult Patients with Peanut Allergy
-
Stated-Preferences in Knee Arthroplasty
-
Study Network of Acinetobacter as a XDR pathogen (SNAP)
-
Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF
-
Study to Evaulate the Kappa Opioid Receptor as a Target for the Treatment of Mood and Anxiety Spectrum Disorders by Evaluating Whether LY2456302 Engages Reward-related Neural Circuitry.
-
Subcontract to UNC: UNC Research Centers for Excellence in Clinical Preventive Services
-
Subcontract: Comparing Traditional and Participatory Dissemination of a Shared Decision Making Intervention
-
Subcontract: Epidemiological and Behavioral Research in Oral Health
-
Subcontract: Epidemiological and Behavioral Research in Oral Health
-
Support for Specimen Banking in ACOSOG GY 6
-
Symptoms of Lower Urinary Tract Dysfunction Research Network (U01) Supplement
-
Synthetic Control Arm for IPF
-
TASK AREA A TASK ORDER FY.2016.A1.0041
-
TASK AREA A, TASK ORDER FY.2020.A1.0127 - Task Area A
-
TASK ORDER FY.2021.A1.0128 - Task Area A
-
TASK ORDER FY.2022.A1.01348 - Task Area A
-
TEMPUS TUMOR ORIGIN TEST
-
TNBC Study
-
TO # 1 - Coordinating Center for Cardiovascular Disease
-
TO # 1 - Coordinating Center for Cardiovascular Disease - OPTION YEAR 2
-
TO#4 CC Leadership
-
TOMMORROW DATA SHARING TO ADVANCE PRE-DEMENTIA CLINICAL TRIALS
-
TRANSFORM-HF CCC
-
TRANSFORM-HF DCC
-
TRC-THD Administrative Coordinating Center (ACC)
-
Task Order 1: CC Phase II Master Contract Leadership
-
Task Order 7: Front Door
-
The Aga Khan University-Pakistan Initiative for NCDs (AKUPI-NCDs)
-
The Congenital Heart Technical Skill Study: Improving Outcomes for Infants and Children with Congenital Heart Disease
-
The Data FITS Study of EHR-to-EDC eSource Data Collection
-
The ISCHEMIA Trial - EQOL
-
The ISCHEMIA Trial - SDCC
-
The ISCHEMIA Trial - SDCC
-
The ISCHEMIA Trial - SDCC- Subcontract with NYU
-
The Impact of Quality Metrics on Outcomes among Elderly Heart Failure Patients
-
The Jahnigen Career Development Award (JCDA)
-
The Lung Transplant Clinical Trials Network (LT-CTN)
-
The NAD+ Baseline Study
-
The North Carolina Congenital Heart Disease Surveillance Network
-
The Pharmacokinetics of Extended Duration High-dose Cefixime Co-administered with Azithromycin for the Decreased Susceptibility of Neisseria gonorrhoeae: A Phase I Pilot Study
-
The Pharmacokinetics of Extended Duration High-dose Cefixime Co-administered with Azithromycin for the Decreased Susceptibility of Neisseria gonorrhoeae: A Phase I Pilot Study, Option 1
-
The Project Baseline Community Study (#101143)
-
The Southern Consortium Node of the Clinical Trials Network
-
The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization
-
Thrombolysis in Ischemic Stroke Patients: Recent Stroke,AM Infarction,Major Surgery, Combo Prev Stroke Diabetes Mellitus
-
Thyrogen Utilization Patterns in the Treatment of Thyroid Cancer
-
Tools for Economic Analysis of Patient Management Interventions in Heart Failure
-
Topic Briefs TO#4_Disease Modifying Therapies on Multiple Sclerosis
-
Topic Refinement 2015
-
Topic Refinement 2015
-
Topic Refinement, Task order 8 PCSK9
-
Topic Refinement, Task order 9 Topic Briefs
-
Towards an Understanding of the Pathophysiology and Clinical Outcomes of Patients w/Endocarditis
-
Training for Clinical Research in Hearing Balance and Other Communication Disorders
-
Transition of Care for Acute Stroke and Myocardial Infarction Patients
-
Translating CER results from ICU study to improve outcomes in cardiac surgery NCE
-
Treating Pain in Fibromyalgia
-
Treatment Switching Behavior among Multiple Myeloma Patients
-
Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal
-
Trial to Assess Chelation Therapy 2 (TACT2) Data Coordinating Center
-
Trial to Assess the Effects of Medication Therapy Managment
-
UAMS Subcontract_IDeA States Mentorship
-
UCB Patient Insights Project
-
UCB-UNC Fellowship in Neurology Clinical Drug Development
-
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
-
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
-
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
-
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
-
Understanding Patient Expectations of Treatment Outcomes
-
Understanding Quality and Costs in Congenital Heart Surgery
-
Urinary Dysfunction in the Elderly: Informing Accountable Urologic Care
-
Urinary Stone Disease Research Network: Scientific Data Research Center
-
Using AACT - to answer Oncology landscape portfolio of open trials
-
Using PCORnet to Compare Blood Pressure Control Strategies (Subaward to UCSF)
-
Using Unsupervised Learning to Generate Code Mapping Algorithms to Harmonize Data Across Data Systems (DI4)
-
Using the NIH Collaboratory Distributed Research Network to Identify and Characterize ADRD patients
-
VA IPA for Yanhong Li
-
VA Merit Grant- IPA Agreement
-
VA Net, Coordinating and Operations Research Center
-
VAC057: Assess the reactogenicity, safety, and immunogenicity of a live attenuated universal influenza vaccine
-
VCID Biomarkers Coordinating Center
-
VICTORIA Registry
-
VITALITY
-
Vaccine Trial_LOI
-
Validating and Extending the PROMIS Sexual Function Measure for Clinical Research
-
Value of Information Analysis: PCORnet Aspirin Maintenance Doseage Trial
-
Variability, Medical Therapy, and Outcomes in Patients with Peripheral Artery Disease Who Undergo Lower Extremity Endovascular Revascularization Procedures
-
Variation in Human Platelet Function: PAR4 Functional Genomics
-
Vascular Protection Initiative
-
Vericiguat VICTORIA
-
Vesalius Real Registry
-
Victoria Econ
-
Vitamin D Supplementation in Children with Obesity-Related Asthma (VDORA1)
-
Warfarin versus Direct Oral Anticoagulants for Secondary Prevention of Recurent Venous Thromboembolism
-
Wisconsin - Update the PHS sponsored clinical practice
-
Women with BRCA-mutated Advanced Stage Ovarian Cancer
-
You and Me Healthy: Testing Protocol
-
a retrospective re-review of all negatively adjudicated events (NAE) across three (3) protocols/studies
-
cVAD and QI Registries Manuscripts
-
eConnectivity COPD Study LOI